MONTE ROSA THERAPEUTICS INC. - COMMON STOCK

Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

22 نوفمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates

10 نوفمبر 2021 06:30:01 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit

20 أكتوبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer

07 أكتوبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference

30 سبتمبر 2021 15:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes

10 سبتمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

08 سبتمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

12 أغسطس 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

23 يونيو 2021 19:20:00 بحسب Nasdaq GlobeNewswire